Intravenous iron administration: New observations and time for The next steps

5Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Kidney International, The Dialysis Outcomes and Practice Patterns Study reports that hemodialysis patients with monthly intravenous iron supplementation of 300-399 mg or ≥400 mg had a 13 or 18% higher risk of dying, respectively, compared with those receiving 100-199 mg per month, with no obvious differences in cause-specific mortalities. This study supports that randomized controlled trials are urgently needed to identify optimized iron supplementation strategies for anemic dialysis patients.

Cite

CITATION STYLE

APA

Weiss, G., & Kronenberg, F. (2015, January 3). Intravenous iron administration: New observations and time for The next steps. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2014.324

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free